Hospira Investors Go After Board Over Inflated Stock Prices

Law360, New York (December 22, 2011, 7:31 PM EST) -- A Hospira Inc. shareholder sued members of the drugmaker's board of directors Wednesday in Illinois federal court, accusing them of failing in their duties to the company, leading to manufacturing problems and regulatory probes, and artificially inflating stock prices by withholding this damaging information.

Shareholder Robert J. Casey II says Hospira executives, including Chairman of the Board Christopher Begley and CEO F. Michael Ball, failed to manage the company properly, causing production breakdowns and manufacturing deficiencies that will take three years and hundreds of millions of...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

Casey v. Begley et al


Case Number

1:11-cv-09074

Court

Illinois Northern

Nature of Suit

160(Contract: Stockholders Suits)

Judge

Honorable John J. Tharp, Jr

Date Filed

December 20, 2011

Companies

Government Agencies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.